Results 1 to 10 of about 645,718 (276)
Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice [PDF]
Vaccines, 2020 Bordetella pertussis whole-cell vaccines (wP) caused a spectacular drop of global pertussis incidence, but since the replacement of wP with acellular pertussis vaccines (aP), pertussis has resurged in developed countries within 7 to 12 years of the ...
Jana Holubová +7 more
doaj +3 more sources
Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy [PDF]
Med Princ Pract, 2022 Pertussis is a common respiratory infection caused by the bacterium Bordetella pertussis. Although most cases occur in developing countries, it is considered endemic globally.
Mohammad Alghounaim +4 more
semanticscholar +2 more sources
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis [PDF]
Emerg Infect Dis, 2021 Recent reemergence of pertussis (whooping cough) in highly vaccinated populations and rapid expansion of Bordetella pertussis strains lacking pertactin (PRN), a common acellular vaccine antigen, have raised the specter of vaccine-driven evolution and ...
Longhuan Ma +3 more
semanticscholar +2 more sources
Frontiers in Cellular and Infection Microbiology, 2019 Pertussis is a respiratory infectious disease that has been resurged during the last decades. The change from the traditional multi-antigen whole-cell pertussis (wP) vaccines to acellular pertussis (aP) vaccines that consist of a few antigens formulated ...
María Eugenia Zurita +7 more
doaj +2 more sources
Recommendation for the use of newly introduced Tdap vaccine in Korea [PDF]
Korean Journal of Pediatrics, 2011 Pertussis is an acute respiratory infection characterized by paroxysmal cough and inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly after the introduction of DTwP/DTaP vaccine, but the incidence of pertussis has ...
Kyong Min Choi +9 more
doaj +5 more sources
Frontiers in Immunology, 2023 Pertussis is a severe human respiratory tract infectious disease caused by Bordetella pertussis that primarily affects infants and young children.
Jingjing Gao +6 more
doaj +1 more source
Frontiers in Immunology, 2023 Despite the high coverage of pertussis vaccines in high-income countries, pertussis resurgence has been reported in recent years, and has stimulated interest in the effects of vaccines and vaccination strategies. Immunoglobulin G (IgG) antibodies against
Zhiying Yin +8 more
doaj +1 more source
Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination. [PDF]
PLoS ONE, 2016 Despite the high coverage of prophylactic vaccine against Bordetella pertussis infection in many countries for more than three decades, pertussis remains a common vaccine-preventable disease. Infections have been detected more commonly in countries using
Nasamon Wanlapakorn +5 more
doaj +1 more source
Биопрепараты: Профилактика, диагностика, лечение, 2021 Some scientific publications contain data suggesting the “return” or “resurgence” of pertussis. Prevention and elimination of pertussis can only be achieved by extensive immunisation of susceptible populations with a highly effective vaccine.
I. A. Alekseeva +2 more
doaj +1 more source
Angewandte Chemie, 2020 The 60-year high Bordetella pertussis ( B. pertussis ) infection rate in the world suggests the urgent need for new anti-pertussis vaccines. Lipopolysaccharide (LPS) of B. pertussis is an attractive antigen for vaccine development.
Peng Wang +7 more
semanticscholar +1 more source